GB0721605D0 - Prostrate cancer susceptibility screening - Google Patents

Prostrate cancer susceptibility screening

Info

Publication number
GB0721605D0
GB0721605D0 GB0721605A GB0721605A GB0721605D0 GB 0721605 D0 GB0721605 D0 GB 0721605D0 GB 0721605 A GB0721605 A GB 0721605A GB 0721605 A GB0721605 A GB 0721605A GB 0721605 D0 GB0721605 D0 GB 0721605D0
Authority
GB
United Kingdom
Prior art keywords
cancer susceptibility
prostrate cancer
susceptibility screening
screening
prostrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0721605A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Priority to GB0721605A priority Critical patent/GB0721605D0/en
Publication of GB0721605D0 publication Critical patent/GB0721605D0/en
Priority to PCT/GB2008/003711 priority patent/WO2009056862A2/en
Ceased legal-status Critical Current

Links

GB0721605A 2007-11-02 2007-11-02 Prostrate cancer susceptibility screening Ceased GB0721605D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0721605A GB0721605D0 (en) 2007-11-02 2007-11-02 Prostrate cancer susceptibility screening
PCT/GB2008/003711 WO2009056862A2 (en) 2007-11-02 2008-10-31 Prostate cancer susceptibility screening

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0721605A GB0721605D0 (en) 2007-11-02 2007-11-02 Prostrate cancer susceptibility screening

Publications (1)

Publication Number Publication Date
GB0721605D0 true GB0721605D0 (en) 2007-12-12

Family

ID=38834783

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0721605A Ceased GB0721605D0 (en) 2007-11-02 2007-11-02 Prostrate cancer susceptibility screening

Country Status (2)

Country Link
GB (1) GB0721605D0 (en)
WO (1) WO2009056862A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009147201A2 (en) 2008-06-04 2009-12-10 Modiquest B.V. Anti-inflammatory agents
SG10201912361VA (en) 2010-07-27 2020-02-27 Genomic Health Inc Method for using gene expression to determine prognosis of prostate cancer
WO2012029080A1 (en) * 2010-08-30 2012-03-08 Decode Genetics Ehf Sequence variants associated with prostate specific antigen levels
WO2012031207A2 (en) 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
CN103060432B (en) * 2012-10-19 2014-07-23 卫生部北京医院 Method and detection kit for predicting susceptibility to prostate cancer
CN103060434B (en) * 2012-10-19 2014-07-23 卫生部北京医院 Reagent and method for predicting susceptibility to prostate cancer
CN103432593B (en) * 2013-08-01 2015-04-15 中山大学附属肿瘤医院 Medicine composition for preventing or treating esophageal carcinoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
WO2005007830A2 (en) * 2003-07-14 2005-01-27 Mayo Foundation For Medical Education And Research Methods and compositions for diagnosis, staging and prognosis of prostate cancer

Also Published As

Publication number Publication date
WO2009056862A2 (en) 2009-05-07
WO2009056862A3 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
GB2468006B (en) Screening
EP2115659A4 (en) Secure serial number
GB0625321D0 (en) Cancer biomarker
IL190382A0 (en) Detecting prostate cancer
EP2213705A4 (en) Photoluminescent pigment
GB0721605D0 (en) Prostrate cancer susceptibility screening
TWI351135B (en) Complex antenna
GB2453029B (en) Well screens
EP2150626A4 (en) Epigenetic methods
GB0618429D0 (en) Cancer test
ZA201000768B (en) Screens
GB0713192D0 (en) Anti-tumour methods
GB0711341D0 (en) Multilevel screening
GB0712363D0 (en) Detectors
PL384050A1 (en) Potato chrisps
PL384049A1 (en) Potato chrisps
GB0715306D0 (en) Screening
GB0720334D0 (en) Cancer biomarker
GB0709410D0 (en) Chemical screening
GB0710245D0 (en) Plasmonic elements
HK1101865A2 (en) Improved earring
GB0702359D0 (en) Ligand
GB0719474D0 (en) Screens
AU314016S (en) Luggage
AU314021S (en) Luggage

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)